Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Elanco Animal Health Inc (ELAN)

Elanco Animal Health Inc (ELAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Beat Estimates

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 15.38% and 1.80%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for...

ELAN : 26.57 (-2.42%)
Healthcare Stock Earnings Slated on Nov 6: HUM, ELAN & More

Rise in senior population, shift of care to lower-cost settings and decline in unemployment are likely to have driven healthcare sector earnings.

HUM : 317.56 (-0.01%)
LHCG : 127.24 (+0.70%)
CRL : 132.01 (+1.15%)
ELAN : 26.57 (-2.42%)
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q3 Earnings Expected to Decline

Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ELAN : 26.57 (-2.42%)
Zoetis Appoints Kristin Peck as New CEO, Alaix to Retire

Zoetis (ZTS) names executive vice president Kristin Peck as the new CEO, effective Jan 1, 2020.

PFE : 36.93 (-0.32%)
BAYRY : 19.4600 (-0.31%)
ZTS : 117.03 (-0.70%)
ELAN : 26.57 (-2.42%)
Zoetis (ZTS) Receives EC Approval for Simparica Trio in Dogs

Zoetis' (ZTS) leading animal health portfolio gets a boost with the approval of Simparica Trio.

BAYRY : 19.4600 (-0.31%)
ZTS : 117.03 (-0.70%)
FGEN : 35.40 (-14.94%)
ELAN : 26.57 (-2.42%)
Elanco to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference

Elanco Animal Health, Inc. (NYSE: ELAN) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Wednesday, Sept. 11, 2019, in New York. Jeff Simmons, Elanco president and chief...

MS : 49.09 (-0.12%)
ELAN : 26.57 (-2.42%)
Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco

Bayer (BAYRY) inks deal with Elanco to divest its animal health business for $7.6 billion.

LLY : 112.80 (-0.64%)
BAYRY : 19.4600 (-0.31%)
PFE : 36.93 (-0.32%)
ELAN : 26.57 (-2.42%)
Bayer Sells Animal Health Division to Elanco: Now What?

On Tuesday, Bayer (BAYRY) announced the sale of its animal-health division to American competitor Elanco (ELAN), for a net price of $7.6 billion. The deal is expected to close in mid-2020 after regulatory...

PFE : 36.93 (-0.32%)
BAYRY : 19.4600 (-0.31%)
MRK : 83.28 (-0.37%)
ABBV : 85.66 (+0.53%)
LLY : 112.80 (-0.64%)
ZTS : 117.03 (-0.70%)
ELAN : 26.57 (-2.42%)
Home Depot and Moderna rise while Fabrinet and Sarepta fall

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:

KSS : 57.01 (-0.05%)
HD : 231.80 (-0.45%)
BIDU : 120.87 (-2.96%)
MRNA : 17.40 (-0.51%)
MDT : 107.96 (+0.87%)
ELAN : 26.57 (-2.42%)
SRPT : 94.78 (-1.56%)
Elanco Finalizes Acquisition of Aratana Therapeutics

Elanco Animal Health Incorporated (NYSE: ELAN), today finalized the acquisition of Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics...

ELAN : 26.57 (-2.42%)
PETX : 4.92 (-0.20%)
Elanco Appoints Art A. Garcia to Board of Directors

Elanco Animal Health (NYSE: ELAN) today announced the appointment of Art A. Garcia, recently retired executive vice president and chief financial officer of Ryder System Inc., to the Board...

LLY : 112.80 (-0.64%)
R : 53.93 (+0.13%)
ELAN : 26.57 (-2.42%)
ARATANA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aratana Therapeutics - PETX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Aratana Therapeutics (NasdaqGM: PETX)...

PETX : 4.92 (-0.20%)
ELAN : 26.57 (-2.42%)
Lilly (LLY) Down Despite Q1 Earnings Beat on Sales View Cut

Eli Lilly's (LLY) earnings beat estimates in Q1. Stock falls in pre-market trading as the company lowers its full-year revenue forecast.

LLY : 112.80 (-0.64%)
AMGN : 220.70 (-0.19%)
TEVA : 9.33 (+0.32%)
ELAN : 26.57 (-2.42%)
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Aratana Therapeutics, Inc. (PETX) on Behalf of Stockholders and Encourages PETX Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Aratana Therapeutics, Inc. (NASDAQ: PETX) on behalf of stockholders concerning the proposed merger with Elanco...

PETX : 4.92 (-0.20%)
ELAN : 26.57 (-2.42%)
QTNA, PETX, and SFS SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

Rigrodsky & Long, P.A. announces that it is investigating:

ON : 21.50 (-0.60%)
QTNA : 24.51 (+1.07%)
ELAN : 26.57 (-2.42%)
SFS : 6.50 (+0.15%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Aratana Therapeutics, Inc. to Elanco Animal Health Incorporated is Fair to Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

PETX : 4.92 (-0.20%)
ELAN : 26.57 (-2.42%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aratana Therapeutics, Inc.

Rowley Law PLLC is investigating potential claims against Aratana Therapeutics, Inc. (NASDAQ: PETX) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company...

PETX : 4.92 (-0.20%)
ELAN : 26.57 (-2.42%)
Aratana Therapeutics to be Acquired by Elanco Animal Health

Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, announced it has signed an agreement to be acquired...

PETX : 4.92 (-0.20%)
ELAN : 26.57 (-2.42%)
Investor Expectations to Drive Momentum within Dermira, Elanco Animal Health, Ready Capital, Cushman & Wakefield, BlueLinx, and Lydall -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Dermira, Inc. (NASDAQ:DERM), Elanco...

DERM : 8.05 (-2.19%)
ELAN : 26.57 (-2.42%)
RC : 15.85 (-0.06%)
CWK : 18.93 (+1.39%)
BXC : 15.47 (-8.84%)
LDL : 19.33 (+0.57%)
MagnaChip and ELAN Microelectronics Announce Partnership to Expand OLED Display Capabilities for Next-Generation Applications

MagnaChip Semiconductor Corporation ("MagnaChip" or the "Company") (NYSE: MX), a designer and manufacturer of analog and mixed-signal semiconductor products, and ELAN Microelectronics Corp. (TWSE:ELAN),...

MX : 12.10 (-2.34%)
ELAN : 26.57 (-2.42%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.30 , AIZ -0.99 , SBAC +0.16 , SO -0.79 , WELL +0.23
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar